EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Neuroprotective mechanisms of dexmedetomidine in perioperative neurocognitive disorders: From molecular pathways to clinical translation

Zhi Shang, Yuyang Wu, Chen Gu, Ju Gao, Cunjin Wang

Journal of Anesthesia and Translational Medicine · 2025-12 · 4 (4) · 220-230

DOI: 10.1016/j.jatmed.2025.11.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Anesthesia and Translational Medicine, 2025-12. Verfasst von Zhi Shang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College, Yangzhou University, Yangzhou 225001, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, 333 Project of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perioperative neurocognitive disorders (PNDs) are common severe complications observed in elderly patients following surgery, primarily characterized by a decline in postoperative cognitive function and memory. Dexmedetomidine, a highly selective α2-adrenergic receptor agonist, has garnered increasing attention due to its notable neuroprotective properties. This article comprehensively reviews the multifaceted neuroprotective mechanisms of dexmedetomidine in the prevention and management of PNDs, encompassing inhibition of neuroinflammation, mitigation of oxidative stress, reduction of cellular apoptosis, preservation of the blood-brain barrier, and regulation of metabolic reprogramming. Furthermore, this review delves into the clinical translational applications and future research directions of dexmedetomidine, offering a theoretical foundation for the development of more efficacious strategies in the prevention and treatment of PNDs.

Schlagwörter

Stichwörter der Autor:innen

Clinical translationDexmedetomidineMolecular pathwaysNeuroprotectionPerioperative neurocognitive disorders

Autor:innen und Institutionen

  • Clinical Medical College, Yangzhou University, Yangzhou 225001, China.
  • Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China.
  • Department of Anesthesiology, Northern Jiangsu People's Hospital, Yangzhou 225001, China.
  • Department of Pain Treatment, Northern Jiangsu People's Hospital, Yangzhou 225001, China.
  • The Yangzhou Clinical Medical College of Xuzhou Medical University, Yangzhou 225001, China.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • 333 Project of Jiangsu Province
  • National Natural Science Foundation of China
  • Jiangsu Association for Science and Technology

Zitieren

APA

Shang, Z., Wu, Y., Gu, C., Gao, J., & Wang, C. (2025). Neuroprotective mechanisms of dexmedetomidine in perioperative neurocognitive disorders: From molecular pathways to clinical translation. Journal of Anesthesia and Translational Medicine, 4(4), 220-230. https://doi.org/10.1016/j.jatmed.2025.11.001

Vancouver

Shang Z, Wu Y, Gu C, Gao J, Wang C. Neuroprotective mechanisms of dexmedetomidine in perioperative neurocognitive disorders: From molecular pathways to clinical translation. Journal of Anesthesia and Translational Medicine. 2025;4(4):220-230. doi:10.1016/j.jatmed.2025.11.001

BibTeX
@article{Shang2025,
  author = {Shang, Zhi and Wu, Yuyang and Gu, Chen and Gao, Ju and Wang, Cunjin},
  title = {Neuroprotective mechanisms of dexmedetomidine in perioperative neurocognitive disorders: From molecular pathways to clinical translation},
  journal = {Journal of Anesthesia and Translational Medicine},
  year = {2025},
  volume = {4},
  number = {4},
  pages = {220--230},
  doi = {10.1016/j.jatmed.2025.11.001}
}
Kostenlos starten →